ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Significance of DSA Clearance in Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients on 1 Year Outcomes: Interim Results from PARAMOUr “Pediatric Renal AMr Outcomes” Study

I. Ashoor1, R. Garro2, S. Solomon3, A. Jain4, M. Kallash5, K. Twombley6

1LSHUSC Children's Hospital New Orleans, New Orleans, LA, 2Emory University School of Medicine, Atlanta, GA, 3New York Medical College, Valhalla, NY, 4Wayne State University School of Medicine, Detroit, MI, 5Nation Wide Children's Hospital, Columbus, OH, 6Medical University of South Carolina, Charleston, SC

Meeting: 2020 American Transplant Congress

Abstract number: C-048

Keywords: HLA antibodies, Outcome, Pediatric, Rejection

Session Information

Session Name: Poster Session C: Kidney: Pediatrics

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Little is known about how donor specific antibody (DSA) clearance correlates with outcomes in pediatric antibody mediated rejection (AMR). There is also little data on how different AMR treatments affect DSA clearance.

*Methods: We collected data from 6 centers within the Pediatric Nephrology Research Consortium to review treatment patterns and outcomes. Pediatric renal transplant recipients between 0 to 18 years old at time of transplant with biopsy proven AMR between 12/31/2009-12/31/2017 and followed for 12 consecutive months were included. DSA clearance was defined as the percentage that DSA decreased within a year post treatment. Categorical variables are presented as relative frequencies and normally distributed continuous variables are presented as means ± standard deviations with differences assessed by two-tailed t-tests. Descriptive statistics were evaluated by frequencies, medians and ranges or means and confidence intervals. P values for race, gender and donor type were obtained by comparing to SRTR data.

*Results: We have reviewed 42 AMR episodes to date from 40 patients. Baseline data is available in table 1.

 border=

African Americans (AA), males and those with decreased donor (DD) grafts were most common in our cohort. There was data on DSA within a year of treatment on 37 episodes. Class II was the dominant DSA in 81.1 % (30/37) and Class I was dominant in 19.9 % (9/37). DQ was the most common immunodominant DSA (iDSA) 64.9% (24/37). Total percent of iDSA that was cleared with any treatment was 27.38%. There was no difference in the % of iDSA cleared between those that received bortezomib vs. no bortezomib (36.95% vs. 40.21%), or between those that received thymoglobulin vs. no thymoglobulin (30.68% vs. 41.68%). There was no difference in 1 yr GFR between those that cleared >50% of the iDSA vs <50% (34.8 vs 34.8; p=0.99).

*Conclusions: Class II DSA are the most common iDSA seen in Pediatric AMR and DQ was the most common class II iDSA seen in our cohort. There was no correlation between clearance of DSA and 1 year GFR. There was no difference in the iDSA clearance between medications used to treat the DSA. AA, males and those with DD grafts were most common in our cohort. Larger studies are needed to confirm our findings.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ashoor I, Garro R, Solomon S, Jain A, Kallash M, Twombley K. Significance of DSA Clearance in Antibody Mediated Rejection in Pediatric Kidney Transplant Recipients on 1 Year Outcomes: Interim Results from PARAMOUr “Pediatric Renal AMr Outcomes” Study [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/significance-of-dsa-clearance-in-antibody-mediated-rejection-in-pediatric-kidney-transplant-recipients-on-1-year-outcomes-interim-results-from-paramour-pediatric-renal-amr-outcomes/. Accessed May 10, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences